ARCHIVES

Single-Agent Phase III Trial Comparing Vectibix to Erbitux Meets Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 36 No. 5 | May 31, 2013

Download PDF Visit The Full Archive

Related Articles

In Brief: DCCR Advisory Committee Meeting Rescheduled; Durant To Head Cooperative Group Chairman

June 29, 1979

Ibrutinib Demonstrates Responses In Large B-Cell Lymphomas

April 27, 2012

In Brief: Alice Fordyce, Supporter of Medical Research, Dead At 86; Broder Awarded Block Lectureship

September 18, 1992

Funding Opportunities

September 6, 2002

Chest X-Ray Produces Many False-Positive Results

January 27, 2006

NCA Declines To Set Minimum Comp Center Bed Number

April 2, 1976